Busschbach JJ - Search Results

1

Valuation of EQ-5D health states in Poland: first TTO-based social value set in Central and Eastern Europe.

Golicki D, Jakubczyk M, Niewada M, Wrona W, Busschbach JJ. Golicki D, et al. Among authors: busschbach jj. Value Health. 2010 Mar-Apr;13(2):289-97. doi: 10.1111/j.1524-4733.2009.00596.x. Epub 2009 Sep 10. Value Health. 2010. PMID: 19744296 Free article.

2

Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets.

van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard AS. van Hout B, et al. Value Health. 2012 Jul-Aug;15(5):708-15. doi: 10.1016/j.jval.2012.02.008. Epub 2012 May 24. Value Health. 2012. PMID: 22867780 Free article.

3

Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study.

Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J. Janssen MF, et al. Qual Life Res. 2013 Sep;22(7):1717-27. doi: 10.1007/s11136-012-0322-4. Epub 2012 Nov 25. Qual Life Res. 2013. PMID: 23184421 Free PMC article.

4

Quality Control Process for EQ-5D-5L Valuation Studies.

Ramos-Goñi JM, Oppe M, Slaap B, Busschbach JJ, Stolk E. Ramos-Goñi JM, et al. Among authors: busschbach jj. Value Health. 2017 Mar;20(3):466-473. doi: 10.1016/j.jval.2016.10.012. Epub 2016 Dec 22. Value Health. 2017. PMID: 28292492 Free article.

5

The Indonesian EQ-5D-5L Value Set.

Purba FD, Hunfeld JAM, Iskandarsyah A, Fitriana TS, Sadarjoen SS, Ramos-Goñi JM, Passchier J, Busschbach JJV. Purba FD, et al. Pharmacoeconomics. 2017 Nov;35(11):1153-1165. doi: 10.1007/s40273-017-0538-9. Pharmacoeconomics. 2017. PMID: 28695543 Free PMC article.

6

Selecting Health States for EQ-5D-3L Valuation Studies: Statistical Considerations Matter.

Yang Z, Luo N, Bonsel G, Busschbach J, Stolk E. Yang Z, et al. Value Health. 2018 Apr;21(4):456-461. doi: 10.1016/j.jval.2017.09.001. Epub 2017 Oct 18. Value Health. 2018. PMID: 29680103 Free article.

7

Test-Retest Reliability of EQ-5D-5L Valuation Techniques: The Composite Time Trade-Off and Discrete Choice Experiments.

Purba FD, Hunfeld JAM, Timman R, Iskandarsyah A, Fitriana TS, Sadarjoen SS, Passchier J, Busschbach JJV. Purba FD, et al. Value Health. 2018 Oct;21(10):1243-1249. doi: 10.1016/j.jval.2018.02.003. Epub 2018 Mar 26. Value Health. 2018. PMID: 30314626 Free article.

8

Effect of Health State Sampling Methods on Model Predictions of EQ-5D-5L Values: Small Designs Can Suffice.

Yang Z, Luo N, Bonsel G, Busschbach J, Stolk E. Yang Z, et al. Value Health. 2019 Jan;22(1):38-44. doi: 10.1016/j.jval.2018.06.015. Epub 2018 Jul 31. Value Health. 2019. PMID: 30661632 Free article.

9

How Prevalent Are Implausible EQ-5D-5L Health States and How Do They Affect Valuation? A Study Combining Quantitative and Qualitative Evidence.

Yang Z, Feng Z, Busschbach J, Stolk E, Luo N. Yang Z, et al. Value Health. 2019 Jul;22(7):829-836. doi: 10.1016/j.jval.2018.12.008. Epub 2019 Mar 15. Value Health. 2019. PMID: 31277831 Free article.

10

United States Valuation of EQ-5D-5L Health States Using an International Protocol.

Pickard AS, Law EH, Jiang R, Pullenayegum E, Shaw JW, Xie F, Oppe M, Boye KS, Chapman RH, Gong CL, Balch A, Busschbach JJV. Pickard AS, et al. Value Health. 2019 Aug;22(8):931-941. doi: 10.1016/j.jval.2019.02.009. Epub 2019 May 25. Value Health. 2019. PMID: 31426935 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters